44642 
Federal Register / Vol. 52. No. 224 / Friday, November 20, 1987 / Notices 
activities as indicated in the notice. 
Attendance by the public will be limited 
to space available. 
Mrs. Winifred Lumsden, the 
Committee Management Officer, 
National Cancer institute. Building 31, 
Room 10A06, National Institutes of 
Health, Bethesda, Maryland 20892-3100 
(301-496-5708) will provide summaries 
of the meetings and rosters of members 
upon request. 
Other information pertaining to the 
meetings can be obtained from the 
Executive Secretary, Linda M. 
Bremerman, National Cancer Institute, 
Blair Building, Room 1A07, National 
Institutes of Health, Bethesda. Maryland 
20892-4200 (301-^27-8630). 
Name of Committee: Cancer Control 
Science Subcommittee 
Date of Meeting: December 8. 1987, 10 
a.m.-3 p.m. 
Place of Meeting: Building 31, Room 7A- 
14, 9000 Rockville Pike, Bethesda, 
Maryland 20892-3100 
Agenda: Discuss current and future 
programs of the Cancer Control 
Science Program. 
Name of Committee: Prevention 
Subcommittee 
Date of Meeting: January 6. 1988, 1 p.m.- 
adjournment 
Place of Meeting: Building 31, 
Conference Room 2, A Wing, 9000 
Rockville Pike, Bethesda, Maryland 
20892-3100 
Agenda: Discuss current and future 
programs of the Prevention Program. 
Name of Committee: Centers and 
Community Oncology Subcommittee 
Date of Meeting: January 6. 1988, 7 p.m.- 
adjournment. 
Place of Meeting: Building 31. 
Conference Room 7, C Wing. 9000 
Rockville Pike, Bethesda, Maryland 
20892-3100 
Agenda: Discuss current and future 
programs of the Centers and 
Community Oncology Program. 
Name of Committee: Board of Scientific 
Counselors, Division of Cancer 
Prevention and Control 
Dates of Meeting: January 7-8, 1988. 8:30 
a.m.-adjournment 
Place of Meeting: Building 31, 
Conference Room 10. C Wing, 9000 
Rockville Pike. Bethesda. Maryland 
20892-3100 
Agenda: Review progress of programs 
within the Division and review of 
concepts being considered for funding. 
Dated: November 12. 1937. 
Betty J. Beveridge. 
Committee Management Officer. S!H. 
|rR Doc. 87-20768 Filed 11-19-0": 8:15 <iin] 
BILLING CODE 4140-C1-M 
National Cancer Institute; Meeting 
Notice is hereby given to amend the 
notice of the Frederick Cancer Research 
Facility Advisory Committee which was 
published in the Federal Register (52 FR 
41327) on October 27, 1987. The meeting 
was originally scheduled to commence 
at 8 a.m. but will now begin at 8:30 a.m. 
on December 8. 1987, Building 3lC, 
Conference Room 9, at the National 
Institutes of Health, Bethesda, Maryland 
20892. 
The meeting will be open to the public 
on December 8 from 8:30 a.m. to 12 noon 
to discuss administrative matters, future 
meetings, Ten-Year Plan, Fermentation 
Production Plant, and for briefing on 
items of interest to NCI and the 
Committee, including management 
changes, AIDS subcontracts and other 
activities, and results of recompetition. 
Attendance by the public will be limited 
to space available. 
In accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), 
Title 5, U.S.C. and sec. 10(d) of Pub. L. 
92-463, the meeting will be closed to the 
public on December 8 from 12 noon to 
adjournment for discussion of previous 
site visits and review/evaluation of 
research being conducted by the Basic 
Research Program. These discussions 
could reveal confidential trade secrets 
or commercial property such as 
patentable material, and personal 
information concerning individuals 
associated with the contractor, the 
disclosure of which would constitute a 
clearly unwarranted invasion of 
persona! privacy. 
Dated: November 12, 1987. 
Betty J. Beveridge, 
Committee Management Officer. NIH. 
(FR Doc. 87-26767 Filed 11-19-87: 8:45 am] 
BILLING CODE 4140-01-M 
Recombinant DNA Advisory 
Committee, Human Gene Therapy 
Subcommittee; Meeting 
Pursuant to Pub. L. 92-463, notice is 
hereby given of a meeting of the 
Recombinant DNA Advisory Committee 
Human Gene Therapy Subcommittee at 
the National Institutes of Health, 
Building 3lC. Conference Room 9, 9000 
Rockville Pike. Bethesda. Maryland 
20892, on December 7, 1987, from 
approximately 9:00 a.m. to adjournment 
at approximately 5:00 p.m. to review 
submission of preclinical data for 
information purposes, and to review a 
lay summary document. This meeting 
will be open to the public. Attendance 
by the public will be limited to space 
available. 
Further information may be obtained 
from Dr. William J. Gartland. Executive 
Secretary, Recombinant DNA Advisory 
Committee Human Gene Therapy 
Subcommittee, Office of Recombinant 
DNA Activities, 12441 Parklawn Drive, 
Suite 58, Rockville, Maryland 20852. 
telephone (301) 770-0131. 
OMB's "Mandatory Information 
Requirements for Federal Assistance 
Program Announcements" (45 FR 39592) 
requires a statement concerning the 
official government programs contained 
in the Catalog of Federal Domestic 
Assistance. Normally NIH lists in its 
announcements the number and title of 
affected individual programs for the 
guidance of the public. Because the 
guidance in this notice covers nofonly 
virtually every NIH program but also 
essentially every Federal research 
program in which DNA recombinant 
molecule techniques could be used, it 
has been determined to be not cost 
effective or in the public interest to 
attempt to list these programs. Such a 
list would likely require several 
additional pages. In addition, NIH could 
not be certain that every Federal 
program would be included as many 
Federal agencies, as well as private 
organizations, both national and 
international, have elected to follow the 
NIH Guidelines. In lieu of the individual 
program listing, NIH invites readers to 
direct questions to the information 
address above about whether individual 
Program listed in the Catalog of Federal 
Domestic Assistance are affected. 
Date: November 12. 1987. 
Betty J. Beveridge, 
Committee Management Officer. NIH. 
[FR Doc. 87-26768 Filed 11-19-87: 8:45 am] 
BILLING CODE 4140-01-M 
Public Health Service 
National Toxicology Program; 
Completed Short-term Toxicology 
Studies on Two Chemicals; Request 
for Comments 
As part of an effort to inform the 
public and allow interested parties to 
comment and provide information on 
chemicals prior to designing studies for 
long-term toxicology and carcinogenesis 
studies, the National Toxicology 
Program (NTP) will routinely announce 
in the Federal Register the list of 
chemicals for which short-term 
toxicology studies have been completed. 
Short-term toxicology studies on the 
chemicals Used in this announcement 
have been completed and the National 
Institute of Environmental Health 
Sciences (NIEHS)/National Toxicology 
Program (NTP) is in the process of 
evaluating the results. A decisison on 
Recombinant DNA Research, Volume 13 
[ 90 ] 
